Ju Liang
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Supramolecular Self-Assembly in Materials
Papers in
- Biomaterials 15
- Nanoparticle-Based Drug Delivery 14
-
- Advanced Polymer Synthesis and Characterization 5
- Co-authors
- Wen‐Lan Wu (19 shared papers)Junbo Li (17 shared papers)Yubo Li (10 shared papers)Yanjun Zhang (9 shared papers)Xiaoding Xu (1 shared paper)Xian‐Zheng Zhang (1 shared paper)Ren‐Xi Zhuo (1 shared paper)Zhiguo Hou (7 shared papers)
- Journals
- RSC Advances (6 papers)Colloids and Surfaces B Biointerfaces (4 papers)Plant Physiology and Biochemistry (2 papers)New Journal of Chemistry (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ju Liang
49 papers receiving 796 citations
Peers
Comparison fields: 5 of 81
- Drug Discovery 5
- Biomaterials 207
- Complementary and alternative medicine 74
- Pharmacology 55
- Pharmaceutical Science 33
Countries citing papers authored by Ju Liang
This map shows the geographic impact of Ju Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Liang more than expected).
Fields of papers citing papers by Ju Liang
This network shows the impact of papers produced by Ju Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Liang. The network helps show where Ju Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 96 | |
| 2 | 2015 | 73 | |
| 3 | 2013 | 38 | |
| 4 | 2016 | 37 | |
| 5 | 2013 | 35 | |
| 6 | 2023 | 35 | |
| 7 | 2006 | 33 | |
| 8 | 2016 | 29 | |
| 9 | 2016 | 29 | |
| 10 | 2019 | 29 | |
| 11 | 2014 | 24 | |
| 12 | 2015 | 24 | |
| 13 | 2019 | 23 | |
| 14 | 2014 | 21 | |
| 15 | 2023 | 20 | |
| 16 | 2014 | 17 | |
| 17 | 2015 | 16 | |
| 18 | 2017 | 15 | |
| 19 | 2021 | 14 | |
| 20 | 2025 | 14 |
About Ju Liang
Ju Liang is a scholar working on Biomaterials, Organic Chemistry, Molecular Medicine, Pharmaceutical Science and Complementary and alternative medicine, having authored 50 papers that have together received 801 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (14 papers), Advanced Polymer Synthesis and Characterization (5 papers), Metabolomics and Mass Spectrometry Studies (5 papers), Curcumin's Biomedical Applications (3 papers), Advanced Drug Delivery Systems (3 papers), RNA Interference and Gene Delivery (3 papers), Gold and Silver Nanoparticles Synthesis and Applications (3 papers) and Plant Stress Responses and Tolerance (2 papers). The work is most often cited by research in Drug Discovery (5 citations), Biomaterials (207 citations), Complementary and alternative medicine (74 citations), Pharmacology (55 citations) and Pharmaceutical Science (33 citations). Ju Liang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Wen‐Lan Wu, Junbo Li, Yubo Li, Yanjun Zhang, Xiaoding Xu, Xian‐Zheng Zhang, Ren‐Xi Zhuo, Zhiguo Hou, Zhenzhu Zhang and Haoyue Deng. Their work appears in journals such as RSC Advances, Colloids and Surfaces B Biointerfaces, Plant Physiology and Biochemistry, New Journal of Chemistry and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.